Volume 63, Issue 1, Pages (January 2003)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 65, Issue 6, Pages (June 2004)
Volume 54, Issue 2, Pages (August 1998)
Volume 59, Issue 3, Pages (March 2001)
E. Cavalier, P. Delanaye, A. Carlisi, J. -M. Krzesinski, J. -P
Beta blockers in the management of chronic kidney disease
Linear and logistic regression analysis
Volume 57, Issue 4, Pages (April 2000)
C-reactive protein and dialysis access
Volume 55, Issue 2, Pages (February 1999)
Determinants of phosphorus mobilization during hemodialysis
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients  G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,
Volume 56, Issue 3, Pages (September 1999)
Corrections to "Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated.
C-reactive protein and dialysis access
Volume 54, Issue 2, Pages (August 1998)
Volume 78, Pages S41-S45 (August 2010)
Volume 81, Issue 4, Pages (February 2012)
Kamyar Kalantar-Zadeh  Kidney International 
Volume 94, Issue 5, Pages (November 2018)
Volume 82, Issue 1, Pages (July 2012)
Volume 63, Issue 4, Pages (April 2003)
George A. Kaysen, Burl R. Don
Volume 68, Issue 6, Pages (December 2005)
Volume 61, Issue 3, Pages (March 2002)
Volume 56, Issue 5, Pages (November 1999)
Comorbidity and confounding in end-stage renal disease
Volume 57, Issue 4, Pages (April 2000)
Volume 84, Issue 1, Pages (July 2013)
N-terminal fragments of the proatrial natriuretic peptide in patients before and after hemodialysis treatment  Martina Franz, Wolfgang Woloszczuk, Walter.
Joseph W. Eschbach, John W. Adamson  Kidney International 
Body weight is a fluctuating parameter in hemodialysis patients
Volume 87, Issue 2, Pages (February 2015)
Volume 60, Issue 1, Pages (July 2001)
Gentamicin pharmacokinetics during slow daily home hemodialysis
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease  S. Bianchi, R. Bigazzi, V.M. Campese 
Relationship between methylmalonic acid and cobalamin in uremia
Volume 67, Pages S48-S51 (January 2005)
Volume 71, Issue 3, Pages (February 2007)
Blood pressure targets in hemodialysis patients
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 6, Pages (June 2002)
Volume 65, Issue 6, Pages (June 2004)
Albumin-like material in urine
Recent experience with high-dose intravenous iron administration
Volume 54, Issue 2, Pages (August 1998)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 61, Issue 1, Pages (January 2002)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 65, Issue 3, Pages (March 2004)
Volume 55, Issue 5, Pages (May 1999)
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Why measure serum albumin levels?
The course of the remnant kidney model in mice
Volume 80, Issue 10, Pages (November 2011)
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Volume 65, Issue 4, Pages (April 2004)
Volume 60, Issue 6, Pages (December 2001)
Volume 70, Issue 7, Pages (October 2006)
Volume 55, Issue 4, Pages (April 1999)
Yutaka Koda, M.D., Shin-Ichi Nishi, Masashi Suzuki, Yoshihei Hirasawa 
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
Volume 64, Issue 3, Pages (September 2003)
Volume 59, Issue 3, Pages (March 2001)
Volume 66, Issue 4, Pages (October 2004)
Volume 76, Issue 5, Pages (September 2009)
Laura M. Krinsky, William J. Levine  Kidney International 
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,
Presentation transcript:

Volume 63, Issue 1, Pages 315-322 (January 2003) Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen levels in hemodialysis patients1  George A. Kaysen, Joel A. Dubin, Hans-Georg Müller, William E. Mitch, Laura Rosales, Nathan W. Levin  Kidney International  Volume 63, Issue 1, Pages 315-322 (January 2003) DOI: 10.1046/j.1523-1755.2003.00721.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 (A) Relationship between plasma fibrinogen concentration and C-reactive protein (CRP) level following log transformation (R = 0.272;P = 0.22). (B) Relationship between plasma fibrinogen concentration and ceruloplasmin during the baseline cross-sectional measurement (R = 0.317; P = 0.007). Kidney International 2003 63, 315-322DOI: (10.1046/j.1523-1755.2003.00721.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Relationship between plasma fibrinogen concentration and plasma volume (% body weight) during baseline cross sectional measurement (R = 0.516;P< 0.001). Kidney International 2003 63, 315-322DOI: (10.1046/j.1523-1755.2003.00721.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Relationship between plasma fibrinogen concentration and both albumin synthesis in g/1.73m2/day and plasma volume in percent body weight (PV%) at the time of the initial injection of [125]I albumin. Fibrinogen = 603 + (13.14 * albumin synthesis/1.73m2) -[52.67 * PV(%)]; PV, P < 0.0001, r2 = 0.1984; albumin synthesis, P < 0.0001, r2 = 0.1586. Kidney International 2003 63, 315-322DOI: (10.1046/j.1523-1755.2003.00721.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Temporal variation in serum fibrinogen concentration (•; weeks vs. fibrinogen g/L), CRP concentration (▵; weeks vs. CRP mg/dL), albumin (□·; weeks vs. albumin g/dL) and α1 acid glycoprotein (⋄; weeks vs α1 AG g/L) in four consecutive hemodialysis patients in whom CRP changed by at least one order of magnitude during the period of observation. Units were scaled to show protein levels in similar ranges. Kidney International 2003 63, 315-322DOI: (10.1046/j.1523-1755.2003.00721.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Box plots of coefficients of variation (standard deviation divided by mean) of albumin (Alb), transferrin (Trf), C-reactive protein (CRP) α1 acid glycoprotein (α1 AG), ceruloplasmin (Cer), interleukin 6 (IL-6) and fibrinogen (Fib) during sequential measurements in 74 patients on hemodialysis ranging from 3.25 to 67.5 months.*P < 0.05 vs. albumin; +P < 0.05 vs. CRP and IL-6. Kidney International 2003 63, 315-322DOI: (10.1046/j.1523-1755.2003.00721.x) Copyright © 2003 International Society of Nephrology Terms and Conditions